[IKT] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
15-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -69.61%
YoY- -566.32%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 7 46 2 328 1,363 1,407 698 -95.38%
PBT -4,640 -4,641 -5,042 -4,471 -2,636 -2,637 -1,208 145.86%
Tax -4,640 -4,641 -0 -4,471 -2,628 -2,625 -2,841 38.81%
NP -4,640 -4,641 -5,042 -4,471 -2,636 -2,637 -1,208 145.86%
Tax Rate - - - - - - - -
Total Cost 4,646 4,687 5,044 4,800 3,999 4,044 1,906 81.41%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -70,817.14 -10,081.47 -259,342.54 -1,361.26 -193.40 -187.40 -172.95 5475.23%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -1.10 -1.10 -1.20 -1.07 -1.29 -1.57 -0.87 16.97%
EPS Diluted -1.10 -1.10 -1.20 -1.07 -1.29 -1.57 -0.87 16.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.